News
-
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
-
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
-
Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA
-
Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones
-
MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
-
Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration
-
Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
-
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
-
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
-
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
-
Definitieve resultaten van de kapitaalverhoging
-
Final results of the capital increase
-
Final results of the capital increase
-
Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips
-
First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips